Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 16

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 16
---
 business hours, at the principal place of business of the corporation at Office of the Corporate Secretary, STAAR Surgical Company, 25510 Commercentre Drive, Lake Forest, California, 92630. As of the Record Date, there were
[ ] shares of STAAR common stock outstanding and entitled to vote at the Special Meeting.

The presence, by
remote communication or by proxy of the holders of record of a majority of the STAAR common stock entitled to vote at the Special Meeting on the Record Date will constitute a quorum at the Special Meeting. In the event that a quorum is not present
at the Special Meeting, it is expected that the Special Meeting will be adjourned to solicit additional proxies.

Recommendation of the Board and Reasons for the Merger

The Board has unanimously determined that the Merger Agreement and the transactions contemplated thereby, including the Merger, on the terms
and subject to the conditions set forth in the Merger Agreement, are advisable, fair to and in the best interests of STAAR and its stockholders, approved, adopted and declared advisable the execution and delivery of, and entry into, the Merger
Agreement, and directed that the Merger Agreement be submitted to the STAAR stockholders for adoption at the Special Meeting. In its determinations and in reaching its recommendations, the Board held numerous meetings, consulted with STAAR senior
management and its outside legal and financial advisors, and considered a number of factors and a substantial amount of information. For a description of the factors considered by the Board in reaching this decision, including potentially negative
factors against which the anticipated benefits of the Merger were weighed, and additional information on the recommendations of the Board, see the section of this proxy statement titled

-7-

“Proposal 1: Adoption of the Merger Agreement—Recommendation of the Board and Reasons for the Merger—Reasons for the Merger.”

The Board unanimously recommends that you vote: (1) “FOR” the Merger Proposal and (2) “FOR” the Compensation Proposal.

Opinion of STAAR’s Financial Advisor

STAAR retained Citigroup Global Markets Inc. (“Citi”) as its financial advisor in connection with a possible transaction involving
Alcon. In connection with Citi’s engagement, STAAR requested that Citi evaluate the fairness, from a financial point of view, to the holders of STAAR common stock of the Merger Consideration pursuant to the Merger Agreement. On August 4,
2025, at a meeting